Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/08164622.2022.2071603 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Peripapillary pachychoroid syndrome].
Vestn Oftalmol
December 2024
Krasnov Research Institute of Eye Diseases, Moscow, Russia.
Peripapillary pachychoroid syndrome (PPS) is a recently described condition, classified within the pachychoroid disease spectrum characterized by focal or diffuse thickening of the choroid due to dilation of choroidal vessels in the Haller's layer (pachyvessels), thinning of the choriocapillaris and the Sattler's layer, and accompanied by increased choroidal permeability and damage to the retinal pigment epithelium. Unlike other pachychoroid diseases that involve changes in the central retina, PPS presents with choroidal thickening and intra- or subretinal fluid located nasally in the macular region, near the optic disc. This review aims to summarize and analyze current data on the clinical features, pathogenesis, and treatment options for PPS found in the literature.
View Article and Find Full Text PDFRetinal Layer and Choroidal Changes in Deep and Scuba Divers: Evidence of Pachychoroid Spectrum-Like Findings.
J Ophthalmol
November 2024
Ophthalmology Department, Sultan Abdulhamid Han Training and Research Hospital, University of Health Sciences, Istanbul, Türkiye.
Diving is an intense physical activity under hyperbaric and hyperoxic conditions. The aim of this study is to evaluate the long-term effects of diving on the thicknesses of retinal layers and retinal anatomy in professional deep and scuba divers. The study included 52 eyes of deep divers who dive to depths of more than 130 feet (ft), 49 eyes of scuba divers who dive up to 130 ft, and 66 eyes of the control group, consisting of nondiving but regularly exercising males.
View Article and Find Full Text PDFPeripapillary pachychoroid syndrome: clinical insights.
Eye (Lond)
December 2024
Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
PREDNISOLONE EYE DROPS AS A POTENTIAL TREATMENT IN NONNEOVASCULAR PACHYCHOROID-RELATED DISEASES.
Retina
August 2024
Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.
Purpose: To investigate the functional and structural outcomes after treatment with prednisolone eye drops in the following pachychoroid-related diseases: chronic central serous chorioretinopathy, pachychoroid pigment epitheliopathy, and peripapillary pachychoroid syndrome.
Methods: In this retrospective study, 54 eyes of 48 patients with pachychoroid-related disease were treated with prednisolone acetate 1% eye drops 3 times a day. Change in macular volume and retinal central subfield thickness on optical coherence tomography was measured.
Peripapillary pachychoroid syndrome treated with dexamethasone implant: A case report.
Eur J Ophthalmol
September 2024
Eye Unit, Humanitas-Gradenigo Hospital, Turin, Italy.
Purpose: To describe a case of peripapillary pachychoroid syndrome (PPS) in a diabetic patient with cystoid macular edema (CME), treated with intravitreal dexamethasone implant (IDI) injection. This report also illustrates the history of the disease after repeated IDI and dexamethasone topical treatment.
Methods: A case report.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!